Literature DB >> 1268035

Antitumour effect of corynebacterium parvum. Possible mode of action.

M Baum, M Breese.   

Abstract

Mesh:

Year:  1976        PMID: 1268035      PMCID: PMC2025090          DOI: 10.1038/bjc.1976.73

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  19 in total

1.  The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.

Authors:  N Wolmark; B Fisher
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

2.  Protection by corynebacterium granulosum against radiation-induced enhancement of artificial pulmonary metastases of a murine fibrosarcoma.

Authors:  L Milas; N Hunter; I Basić; H R Withers
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

3.  Specific immunosuppression by minute doses of passive antibody. 3. Reversal of suppression by peritoneal exudate cells from immune animals.

Authors:  G Haughton
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

4.  Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth.

Authors:  L H Smith; M F Woodruff
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

5.  Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.

Authors:  B Fisher; N Wolmark; E Saffer; E R Fisher
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

6.  Letter: Methyl-cholanthrene-induced sarcomata in mice after immunisation with Corynebacterium parvum plus syngeneic subcellular membrane fractions.

Authors:  H Baum; M Baum
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

Review 7.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

8.  Effect of corynebacterium parvum on bone marrow cell cultures (38557).

Authors:  N V Dimitrov; S Andre; G Eliopoulos; B Halpern
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

9.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

10.  Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.

Authors:  S E Smith; M T Scott
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

View more
  7 in total

1.  Local microwave hyperthermia (43 degrees C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats.

Authors:  M Janiak; W Hryniewicz; J Jeljaszewicz; G Pulverer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

2.  The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.

Authors:  R G Souter; H W Steer
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

3.  Nutritional requirements of anaerobic coryneforms.

Authors:  D A Ferguson; C S Cummins
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

4.  Canine migration inhibitory factor: effect of Corynebacterium parvum administration.

Authors:  M S Pineiro; C A Bowles; E C Cutchins; M I Bull
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

5.  Alterations of mononuclear phagocyte function induced by Lewis lung carcinoma in C57BL mice.

Authors:  A A Otu; R J Russell; P C Wilkinson; R G White
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

6.  Dysbiosis of skin microbiome and gut microbiome in melanoma progression.

Authors:  Chahrazed Mekadim; Helena Kupcova Skalnikova; Jana Cizkova; Veronika Cizkova; Anna Palanova; Vratislav Horak; Jakub Mrazek
Journal:  BMC Microbiol       Date:  2022-02-25       Impact factor: 3.605

7.  Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.

Authors:  K Moore; W H McBride
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.